These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


231 related items for PubMed ID: 26327703

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT.
    Can J Kidney Health Dis; 2020; 7():2054358120965838. PubMed ID: 33240515
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
    Mistry M, Shea A, Giguère P, Nguyen ML.
    Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188
    [Abstract] [Full Text] [Related]

  • 5. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J, Moffett BS.
    Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
    [Abstract] [Full Text] [Related]

  • 6. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.
    Kessler C, Ng J, Valdez K, Xie H, Geiger B.
    J Hosp Med; 2011 Mar; 6(3):136-40. PubMed ID: 21387549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE, Farrington CA, Wall GC, Belz MM.
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [Abstract] [Full Text] [Related]

  • 9. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K, Flynn J, Okamura D, Zhou L.
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2136-42. PubMed ID: 26576619
    [Abstract] [Full Text] [Related]

  • 12. Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Analysis in British Columbia, Canada.
    Atiquzzaman M, Birks P, Bevilacqua M, Wong MMY, Zheng Y, Djurdjev O, Levin A.
    Can J Kidney Health Dis; 2022 Dec 07; 9():20543581221137177. PubMed ID: 36406867
    [Abstract] [Full Text] [Related]

  • 13. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.
    Hasara S, Dubey J, Amatea J, Finnigan N.
    Am J Emerg Med; 2023 Mar 07; 65():59-64. PubMed ID: 36586223
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Sodium Zirconium Cyclosilicate to Sodium Polystyrene Sulfonate in the Inpatient Management of Acute Hyperkalemia.
    Joyce O, Corpman M.
    J Pharm Pract; 2024 Jun 07; 37(3):728-735. PubMed ID: 37254518
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease.
    Hunt TV, DeMott JM, Ackerbauer KA, Whittier WL, Peksa GD.
    Clin Kidney J; 2019 Jun 07; 12(3):408-413. PubMed ID: 31198541
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia.
    Yoo N, Song YB, Dubinsky I, Altshuler J.
    Ann Pharmacother; 2023 Sep 07; 57(9):1044-1052. PubMed ID: 36637028
    [Abstract] [Full Text] [Related]

  • 19. Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study.
    Yao L, Xing X, Li Y, Zhang F, Li P, Liang X, Wang P.
    J Transl Med; 2022 Jul 25; 20(1):333. PubMed ID: 35879718
    [Abstract] [Full Text] [Related]

  • 20. Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia.
    Nakayama Y, Ueda K, Yamagishi SI, Sugiyama M, Yoshida C, Kurokawa Y, Nakamura N, Moriyama T, Kodama G, Minezaki T, Ito S, Nagata A, Taguchi K, Yano J, Kaida Y, Shibatomi K, Fukami K.
    Clin Exp Nephrol; 2018 Feb 25; 22(1):35-44. PubMed ID: 28421299
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.